Table 1. Characteristics of samples and sample selection.
| FF samples | FFPE samples | |||||
|---|---|---|---|---|---|---|
| Year | Pre-selection | Pre-selection | ||||
| ng/μl | RIN | SAMPLE CODE | ng/μl | RIN | SAMPLE CODE | |
| 2009 | 7.09 | 1.1 | UNSELECTED | 163.47 | 2.5 | UNSELECTED |
| 2008 | 155.72 | 4.7 | 83.63 | 1.1 | ||
| 2011 | 2.79 | N/A | 282.43 | 2.4 | ||
| 2009 | 372.25 | 7.1 | FF_AA6360 | 95.31 | 2.5 | FFPE_AA6364 |
| 2009 | 489.17 | 8 | FF_AA6361 | 321.86 | 2.4 | FFPE_AA6365 |
| 2007 | 145.64 | 6.8 | FF_AA6362 | 48.69 | N/A | FFPE_AA6366 |
| 2006 | 549 | 7.3 | FF_AA6363 | 1452.14 | 1.9 | FFPE_AA6367 |
| 2008 | 66.3 | 2.4 | UNSELECTED | 115.3 | 1 | UNSELECTED |
| 2008 | 225.13 | 4.7 | 322.91 | 2.5 | ||
| 2009 | 211.98 | 1.9 | 53.97 | 2.4 | ||
| 2010 | 154.31 | 3.8 | 37.55 | N/A | ||
All 11 paired samples were from patients with pathologically confirmed GBM. Gray shading indicates samples that were selected for analyses.